These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8413542)

  • 21. Rx drug safety in TN: some successes, some challenges.
    Williams B
    Tenn Med; 2009 Apr; 102(4):21-3, 26-7. PubMed ID: 19385365
    [No Abstract]   [Full Text] [Related]  

  • 22. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 23. Improper use of DEA number again draws physician attack.
    Herrmann ES
    Pa Med; 1998 May; 101(5):1-2. PubMed ID: 9610173
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescription drug dispensing limits and patterns.
    Phillips KA; Liang SY; Haas JS; Stebbins M; Alldredge BK
    Manag Care Interface; 2005 Jul; 18(7):41-6. PubMed ID: 16060485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Make patients aware of discounted prescription drugs.
    Ivey D
    Mich Med; 2009; 108(3):21. PubMed ID: 19489358
    [No Abstract]   [Full Text] [Related]  

  • 26. Lessons learned from a CME course in the proper prescribing of controlled drugs.
    Swiggart W; Spickard A; Dodd DT
    Tenn Med; 2002 May; 95(5):192-3. PubMed ID: 12012851
    [No Abstract]   [Full Text] [Related]  

  • 27. Helping patients. Protecting yourself.
    Guglielmo WJ
    Med Econ; 2004 Jun; 81(12):69-70, 72-4, 76. PubMed ID: 15279400
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
    Morrato EH; Staffa JA
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Summary and conclusions of a review of prescription drug diversion control methods.
    Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M
    NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532
    [No Abstract]   [Full Text] [Related]  

  • 30. A proactive approach to controlled substance refills.
    Willis DR; Eaton G; Mackie P
    Fam Pract Manag; 2010; 17(6):22-7. PubMed ID: 21121583
    [No Abstract]   [Full Text] [Related]  

  • 31. The DEA's Balancing Act to Ensure Public Health and Safety.
    Rannazzisi JT
    Clin Pharmacol Ther; 2007 Jun; 81(6):805-6. PubMed ID: 17505495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription practices of public and private health care providers in Attock District of Pakistan.
    Siddiqi S; Hamid S; Rafique G; Chaudhry SA; Ali N; Shahab S; Sauerborn R
    Int J Health Plann Manage; 2002; 17(1):23-40. PubMed ID: 11963441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The (slowly) vanishing prescription pad.
    Steinbrook R
    N Engl J Med; 2008 Jul; 359(2):115-7. PubMed ID: 18614780
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyberpharmacies and the role of the US Food And Drug Administration.
    Henney JE
    J Med Internet Res; 2001; 3(1):E3. PubMed ID: 11720945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prosecution of physicians for prescribing opioids to patients.
    Reidenberg MM; Willis O
    Clin Pharmacol Ther; 2007 Jun; 81(6):903-6. PubMed ID: 17329989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of concierge care on healthcare and clinical practice.
    Linz AJ; Haas PF; Fallon LF; Metz RJ
    J Am Osteopath Assoc; 2005 Nov; 105(11):515-20. PubMed ID: 16368915
    [No Abstract]   [Full Text] [Related]  

  • 37. Ambulatory drug utilization review: opportunities for improved prescription drug use.
    Lyles A; Sleath B; Fulda TR; Collins TM
    Am J Manag Care; 2001 Jan; 7(1):75-81; quiz 82-3. PubMed ID: 11209452
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of computerized clinical support systems in medical settings: United States, 2001-03.
    Burt CW; Hing E
    Adv Data; 2005 Mar; (353):1-8. PubMed ID: 15759905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmaceutic regulation and inadequate drug prescription in Canada: the case of psychotropic drugs in the 1960s and early 1970s].
    Lexchin J
    Sante Ment Que; 1997; 22(1):283-300. PubMed ID: 9233283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drugs and medical costs: four opportunities for health plans and physicians to make a difference.
    Greczyn RJ
    N C Med J; 2003; 64(6):285-6. PubMed ID: 14983619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.